Answer
Premature and low-birth-weight newborns have an increased risk of hypoglycaemia or hyperglycaemia during intravenous glucose treatment, requiring close monitoring to maintain adequate glucose control and avoid potentially serious long-term adverse effects.
Sources for this answer
- Glucose 40% w/v Concentrate for solution for infusionBaxter Healthcare Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked